0.0724
-0.0046
(-5.97%)
At close: 5:29:37 PM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
43,200
44,047
51,005
56,804
Total Liabilities Net Minority Interest
11,130
13,380
16,494
10,130
Total Equity Gross Minority Interest
32,070
30,667
34,511
46,674
Total Capitalization
32,070
30,667
34,511
46,674
Common Stock Equity
32,070
30,667
34,511
46,674
Capital Lease Obligations
--
4,545
6,038
986
Net Tangible Assets
31,870
30,422
34,266
46,674
Working Capital
30,300
28,330
32,058
45,954
Invested Capital
--
30,667
34,511
46,674
Tangible Book Value
31,870
30,422
34,266
46,674
Total Debt
--
4,545
6,038
986
Share Issued
1,065,525.7220
801,128.8840
652,882.4790
559,846.4920
Ordinary Shares Number
1,065,525.7220
801,128.8840
652,882.4790
559,846.4920
12/31/2021 - 12/19/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APTA.ST Aptahem AB (publ)
1.4050
0.00%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1264
+6.94%
XBRANE.ST Xbrane Biopharma AB (publ)
0.1800
-4.66%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
7.12
-8.25%
BINV.ST BioInvent International AB (publ)
26.50
-5.36%
ONCO.ST Oncopeptides AB (publ)
1.6660
-2.34%
CANTA.ST Cantargia AB (publ)
1.2950
-2.04%
EGTX.ST Egetis Therapeutics AB (publ)
4.0250
-6.50%
FLUI.ST Fluicell AB (publ)
11.66
-14.89%
CAMX.ST Camurus AB (publ)
541.50
-4.16%